Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inogen (DE:6IO)
BERLIN:6IO
Inogen (6IO) Stock Price & Analysis
0 Followers
6IO Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€4.00 - €10.70
Previous Close€8
Volume0.00
Average Volume (3M)1.28K
Market Cap
$184.91M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Beta1.08
Next Earnings
Aug 06, 2024EPS Estimate
-€0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,577,109
10 Day Avg. Volume0
30 Day Avg. Volume1,276
Standard Deviation0.12
R-Squared0.15
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)1.28
Price to Sales (P/S)2.17
Price to Cash Flow (P/CF)-16.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.49Price Target Upside-18.88% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Inogen News
PremiumCompany Announcements
Inogen Announces Executive VP and CMO Departure Plans
PremiumPre-Earnings
Is INGN a Buy, Before Earnings?Bulls Say, Bears Say
Bulls Say
EarningsINGN's revenue and adjusted EBITDA outperformed expectations, indicating a strong financial performance.
ProfitabilityINGN achieved a year-over-year improvement in gross and EBITDA margins, showcasing effective cost management and enhanced profitability.
Sales GrowthB2B sales exceeded estimates, driven by new customer acquisitions and a surge in demand from existing resellers.
Bears Say
GuidanceINGN provided revenue guidance that was below consensus.
Market ShareB2B growth was hurt by a decline in US B2B sales as the company continued to struggle to regain share following its supply constraints.
Sales PerformanceDTC sales missed estimates due to a decline in sales reps and insurance payment rate headwinds.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.52% Other Institutional Investors
97.48% Public Companies and
Individual Investors
6IO FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was €4.00 and its highest was €10.70 in the past 12 months.
What is Inogen’s market cap?
Currently, no data Available
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Aug 06, 2024 which is in 87 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on May 07, 2024. The company reported -€0.576 earnings per share for the quarter, beating the consensus estimate of -€0.703 by €0.127.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Overvalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -€0.55.
How many shares outstanding does Inogen have?
Currently, no data Available
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -€0.576 in its last earnings report, beating expectations of -€0.703. Following the earnings report the stock price went up 0.758%.
Which hedge fund is a major shareholder of Inogen?
Among the largest hedge funds holding Inogen’s share is Hussman Strategic Advisors Inc. It holds Inogen’s shares valued at N/A.
---
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.49 (-18.88% Downside)
€6.49 (-18.88% Downside)
Blogger Sentiment
Bullish
DE:6IO Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-23.78%
12-Months-Change
Fundamentals
Return on Equity
-40.86%
Trailing 12-Months
Asset Growth
-18.17%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
---
6IO Company Deck
---
6IO Earnings Call
Q1 2024
0:00 / 0:00
---
6IO Stock 12 Month Forecast
Average Price Target
€6.49
▼(-18.88% Downside)
Technical Analysis
Best Analysts Covering 6IO
1 Year
1 Year Success Rate
10/16 ratings generated profit
1 Year Average Return
+30.87%
reiterated a sell rating 6 months ago
Copying Robbie Marcus's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +30.87% per trade.
---